Taiwan Liposome Company, Ltd.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Taiwan Liposome Company, Ltd.'s past years’ income statements indicate that its last revenue has decreased compared to the previous period by 51% to $101,928,000. Profit margin reached -965%. Total operating expenses were $1,085,038,000.

Profit Margin

Taiwan Liposome Company, Ltd. (NASDAQ:TLC): Profit margin
2011 78.23M -216.98M -277.36%
2012 240.65M -187.12M -77.76%
2013 158.64M -400.97M -252.75%
2014 95.92M -632.86M -659.77%
2015 59.77M -675.68M -1130.46%
2016 41.67M -824.31M -1978.01%
2017 49.63M -873.96M -1760.78%
2018 62.32M -901.57M -1446.59%
2019 209.14M -807.52M -386.12%
2020 101.92M -983.30M -964.71%

TLC Income Statement (2011 – 2020)

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Revenue
Revenue
101.92M209.14M62.32M49.63M41.67M59.77M95.92M158.64M240.65M78.23M
Cost of revenue
0000000000
Gross profit
101.92M209.14M62.32M49.63M41.67M59.77M95.92M158.64M00
Operating exp.
Research and development
967.50M860.41M832.57M813.25M736.87M634.84M664.44M470.23M374.58M257.33M
Selling and marketing
0000000000
Total operating expenses
1.08B1.01B954.09M948.12M878.37M773.16M767.43M568.37M430.43M303.35M
Operating income
-983.11M-801.60M-891.76M-898.48M-836.69M-713.39M-671.51M-409.73M-189.77M-225.12M
Other income (expenses), net
933K-1.79M-8.94M25.47M12.94M38.16M38.94M9.12M2.90M-8.53M
Income before tax
-982.17M-803.40M-900.70M-873.01M-823.75M-675.23M-632.56M-400.61M-186.87M-216.59M
Income tax expense
1.13M4.12M867K951K563K450K292K359K251K394K
Net income
-983.30M-807.52M-901.57M-873.96M-824.31M-675.68M-632.86M-400.97M-187.12M-216.98M
Earnings per share
Basic EPS
-24.89-24.64-28.75-31.5-29.78-24.5-23.08-16.44-9.5-14.6
Diluted EPS
-24.89-24.64-28.75-31.5-29.78-24.5-23.08-16.44-9.5-14.6